Caliway Biopharmaceuticals (CLBPF) Q2 2026 Earnings

10AprConfirmed
Q3 2025
Q4 2025
Q2 2026
-0.01
-0
-0
-0

Details

Expected EPS
-0.00689062
Actual EPS
-0.00689062
Surprise EPS
0
Surprise Percent
+0%

Description

Caliway Biopharmaceuticals (CLBPF) has reported earnings of -0.00689062 per share for Q2 2026.

0 Comments

Share your thoughts